Alpha DNA Investment Management’s Align Technology ALGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-9
Closed -$4K 122
2021
Q1
$4K Buy
9
+6
+200% +$3.32K ﹤0.01% 391
2020
Q4
$1K Buy
+3
New +$1.35K ﹤0.01% 506

Other funds holding ALGN

Alpha DNA Investment Management's ALGN Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Align Technology (ALGN) in Q2 2021, closing a stake of 9 shares — an estimated $4K sold.

Alpha DNA Investment Management first reported a position in ALGN in Q4 2020 and held it in 2 quarters. The position peaked at $4K in Q1 2021. 851 funds tracked by Wall St. Rank hold ALGN as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Align Technology position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 9 Align Technology shares in Q2 2021, an estimated $4K.
  • Alpha DNA Investment Management first reported a position in Align Technology in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's Align Technology position peaked at $4K in Q1 2021.
  • 851 funds tracked by Wall St. Rank held Align Technology as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.